Feasibility of TruGraf® liver for personalized immunosuppression in liver transplant recipients

被引：0
|
作者：
Moaddab, M. [1 ]
Mobley, C. M. [1 ]
Saharia, A. [1 ]
Connor, A. A. [1 ]
Hobeika, M. [1 ]
Simon, C. J. [1 ]
Cheah, Y. L. [1 ]
Brombosz, E. W. [1 ]
Moore, L. W. [1 ]
Victor, D. W., III [1 ]
Kodali, S. [1 ]
Gaber, A. O. [1 ]
Ghobrial, R. M. [1 ]
机构：
[1] Houston Methodist Hosp, Houston, TX 77030 USA
来源：
LIVER TRANSPLANTATION | 2024年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
eP-163
引用
收藏
页码：168 / 169
页数：2
相关论文
共 50 条
  • [41] Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?
    Coupier, Antoine
    Gallien, Yves
    Boillot, Olivier
    Walter, Thomas
    Guillaud, Olivier
    Vallin, Melanie
    Thimonier, Elsa
    Erard, Domitille
    Dumortier, Jerome
    CLINICAL TRANSPLANTATION, 2023, 37 (01)
  • [42] Do surveillance liver biopsies alter the immunosuppression regimen in pediatric liver transplant recipients?
    Jones, Danielle
    Cousino, David
    Vikraman, Deepak
    Mavis, Alisha
    PEDIATRIC TRANSPLANTATION, 2022, 26
  • [43] Personalized immunosuppression in elderly renal transplant recipients
    Peeters, L. E. J.
    Andrews, L. M.
    Hesselink, D. A.
    de Winter, B. C. M.
    van Gelder, T.
    PHARMACOLOGICAL RESEARCH, 2018, 130 : 303 - 307
  • [44] Immunosuppression in liver transplant
    Di Maira, Tommaso
    Coelho Little, Ester
    Berenguer, Marina
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2020, 46-47
  • [45] Individualizing liver transplant immunosuppression using a phenotypic personalized medicine platform
    Zarrinpar, Ali
    Lee, Dong-Keun
    Silva, Aleidy
    Datta, Nakul
    Kee, Theodore
    Eriksen, Calvin
    Weigle, Keri
    Agopian, Vatche
    Kaldas, Fady
    Farmer, Douglas
    Wang, Sean E.
    Busuttil, Ronald
    Ho, Chih-Ming
    Ho, Dean
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (333)
  • [46] Immunosuppression strategies after liver transplantation: A single centre experience in 57 liver transplant recipients
    Sharma R.
    Rajasekar M.R.
    Raghuvanshi A.
    Indian Journal of Surgery, 2007, 69 (5) : 187 - 190
  • [47] Clinical Safety of Belatacept Bridging Immunosuppression in Liver Transplant Recipients.
    Sparkes, T.
    Masters, B.
    Jason, M.
    Hanish, S.
    Ottmann, S.
    Klassen, D.
    Potosky, D.
    Hutson, W.
    Barth, R.
    LaMattina, J.
    TRANSPLANTATION, 2014, 98 : 711 - 711
  • [48] Clinical Outcome of Liver Transplant Recipients after Successful Immunosuppression Withdrawal
    Tryphonopoulos, Panagiotis
    Ruiz, Phillip
    Weppler, Debbie
    Levi, David M.
    Nishida, Seigo
    Moon, Jang
    Tekin, Akin
    Selvaggi, Gennaro
    Island, Eddie
    Shin, Seung H.
    Defranc, Tamara
    Volsky, Alex
    Sotolongo, Barbara
    Carreno, Manuel
    Torres, Maria B.
    Tzakis, Andreas
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 2 - 2
  • [49] Induction Immunosuppression in ABO-Incompatible Liver Transplant Recipients.
    Shaikh, S.
    Hasan, I.
    Kaur, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 816 - 817
  • [50] Induction Immunosuppression and the Incidence of EBV Viremia in Pediatric Liver Transplant Recipients
    Koh-Pham, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 343 - 343
12345